Company: NIVFW
Filing Date: 2025-10-31
Form Type: 424B3
Source: 0001213900-25-104469
Chunk: 57

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-31
Form: 424B3
Chunk 57
---
 In addition, NewGenIvf will
need to appropriately scale its internal business systems and its client account management and services personnel to serve its growing
client base. Any failure of or delay in these efforts could result in reduced client satisfaction, resulting in decreased sales to new
clients and lower renewal and utilization rates by existing clients, which could hurt its revenue growth and its reputation. Even if
NewGenIvf is successful in these efforts, they will require the dedication of management time and attention. NewGenIvf could also face
inefficiencies or service disruptions as a result of its efforts to scale its internal infrastructure. NewGenIvf cannot be sure that
the expansion and improvements to its internal infrastructure will be effectively implemented on a timely basis, and such failures could
harm its business, financial condition and results of operations.

If NewGenIvf’s new solutions and services are not adopted by its clients, or if it fails to innovate and develop new offerings that are adopted by its clients, its revenue and results of operations may be adversely affected.

To date, NewGenIvf has derived
a substantial majority of its revenue from sales of its fertility services. As NewGenIvf operates in an evolving industry, its long-term
results of operations and continued growth will depend on its ability to successfully develop and market new successful solutions and
services to its clients. If its existing clients do not value and/or are not willing to make additional payments for such new solutions
or services, it could adversely affect its business, financial condition and results of operations. If NewGenIvf is unable to predict
clients’ preferences, if the markets in which NewGenIvf participates change, including in response to government regulation, or
if NewGenIvf is unable to modify its solutions and services on a timely basis, NewGenIvf may lose clients. Its results of operations
would also suffer if its innovations were not responsive to the needs of the clients, appropriately timed with market opportunity or
effectively brought to market.

<div align='center'>33</div>

If NewGenIvf fails to adapt and respond effectively to the changing medical landscape, changing regulations, changing client needs, requirements or preferences, its offerings may become less competitive.

The market in which NewGenIvf
competes is subject to a changing medical landscape and changing regulations, as well as changing client needs, requirements and preferences.
The success of its business will depend, in part, on its ability to adapt and respond effectively to these changes on a